Effect of low dose Semaglutide in people with Type 1 Diabetes and excess weight
No Thumbnail Available
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Obesity is a prevalent problem in people living with T1D (PwT1D), and it has been linked to cardiovascular disease in this population. The use of low dose weekly Semaglutide (0,5 mg) was evaluated in a cohort of PwT1D and excess weight.
Description
Keywords
Type 1 Diabetes, Obesity, GLP-1 receptor agonists